Developmental Pharmacology and Toxicology Grant by NIDDK

NIDDK is offering the Developmental Pharmacology and Toxicology Grant to support multidisciplinary research focusing on the impact of ontogeny on drug metabolizing enzymes, transporters, receptors, and signaling pathways from fetal life to adolescence. The grant aims to enhance understanding of how these factors influence drug action and toxicity through basic and translational research. Applications from institutions or organizations conducting investigator-initiated studies in this field are welcomed. Closing date for submissions is Sep 07, 2016.

Opportunity ID: 239456

Apply

General Information

Document Type::	Grants Notice
Funding Opportunity Number::	PAR-13-307
Funding Opportunity Title::	Developmental Pharmacology and Toxicology: Role of Ontogeny (R03)
Opportunity Category::	Discretionary
Opportunity Category Explanation::
Funding Instrument Type::
Category of Funding Activity::	Environment
Category Explanation::
Expected Number of Awards::
Assistance Listings Number(s)::	93.113 — Environmental Health
Cost Sharing or Matching Requirement::	No
Version::	Synopsis 1
Posted Date::	Aug 05, 2013
Last Updated Date::
Original Closing Date for Applications::	Sep 07, 2016
Current Closing Date for Applications::	Sep 07, 2016
Archive Date::	Oct 08, 2016
Estimated Total Program Funding::
Award Ceiling::	$50,000
Award Floor::	$

Eligibility

Eligible Applicants::

Special district governments

Additional Information on Eligibility::

Other Eligible Applicants include the following:
Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession; Non-domestic (non-U.S.) Entities (Foreign Institutions) are eligible to apply.
Non-domestic (non-U.S.) components of U.S. Organizations are eligible to apply.
Foreign components, as defined in the NIH Grants Policy Statement, are allowed.

Additional Information

Agency Name::	National Institutes of Health
Description::	This Funding Opportunity Announcement (FOA) encourages grant applications from institutions or organizations that propose multidisciplinary, investigator-initiated basic and translational research in developmental pharmacology and toxicology. Particular emphasis should be placed on the role of ontogeny on drug metabolizing enzymes, transporters, receptors and signaling pathways across developmental periods from fetal life to adolescence affecting drug action and toxicity.
Link to Additional Information::
Grantor Contact Information::	If you have difficulty accessing the full announcement electronically, please contact:

Version History

Version	Modification Description	Updated Date
Synopsis 1

Package Status

Below are CLOSED Opportunity Package(s) no longer available for this Funding Opportunity:

Package No: 1

Assistance Listings:
Competition ID:	FORMS-C
Competition Title:	Forms-C
Opportunity Package ID:	PKG00182651
Opening Date:	Sep 16, 2013
Closing Date:	May 07, 2016
Agency Contact Information::	eRA Commons Help Desk
Who Can Apply::	Organization Applicants
mendatory_forms	SF424 (R & R) [V2.0] PHS 398 Research Plan [V2.0] PHS 398 Cover Page Supplement [V2.0] Research and Related Senior/Key Person Profile (Expanded) [V2.0] Research And Related Other Project Information [V1.3] Project/Performance Site Location(s) [V2.0]
optional_forms	R & R Subaward Budget Attachment(s) Form 5 YR 30 ATT [V1.3] Planned Enrollment Report [V1.0] PHS 398 Cumulative Inclusion Enrollment Report [V1.0] PHS 398 Modular Budget [V1.2] Research & Related Budget [V1.3]

Package No: 2